Back to all news
AI Model Improves Differentiation of Brain Tumor Progression from Radiation Necrosis on MRI
A York University-led study shows a novel AI using advanced MRI can distinguish between progressive brain tumors and radiation necrosis more accurately than human assessment.
Key Details
- 1AI model uses attention-guided deep learning with chemical exchange saturation transfer (CEST) MRI.
- 2Study included over 90 patients with brain metastases treated by stereotactic radiosurgery (SRS).
- 3AI achieved over 85% accuracy in distinguishing tumor progression from necrosis, compared to ~60% for standard MRI and ~70% for advanced MRI alone.
- 4Published December 2025 in International Journal of Radiation Oncology, Biology, Physics.
- 5A crucial clinical challenge as treatment decisions for tumor progression vs necrosis are substantially different.
Why It Matters
Differentiating tumor progression from radiation necrosis on MRI post-therapy is a major clinical challenge, as each requires different treatments. AI that improves diagnosis accuracy could substantially impact patient management and outcomes in neuro-oncology.
Source
EurekAlert
Related News
•EurekAlert
AI Accelerates Radiopharmaceuticals, Boosts Personalized Dosimetry in Cancer
Machine learning is driving advancements in radiopharmaceutical drug discovery and optimizing patient-specific dosimetry for precision cancer therapy.
•EurekAlert
Physicians Overly Trust Erroneous AI, Ignore Contradictory Evidence
Physicians tend to trust incorrect AI advice, even when evidence contradicts it, suggesting risks in clinical decision-making with AI tools.
•EurekAlert
Concerns Raised Over Unverified Datasets in AI Health Prediction Models
A new study finds widely used AI health prediction models are built on datasets with unverifiable origins, raising safety and validity concerns.